Arcus Biosciences
Arcus Biosciences is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies. Leveraging expertise in immunology and drug discovery, Arcus Biosciences advances a diverse pipeline of novel antibody and small molecule therapeutics targeting key pathways in the tumor microenvironment. The company collaborates with leading pharmaceutical partners to accelerate the development and commercialization of its oncology candidates. Arcus Biosciences is committed to transforming the treatment landscape for patients with cancer by delivering safe and effective therapies. With a science-driven approach, the company aims to address significant unmet medical needs in oncology through rigorous research, robust clinical trials, and strategic partnerships within the biopharmaceutical industry.
